12:00 AM
 | 
Jan 07, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Entereg alvimopan regulatory update

On Dec. 21, 2012, Cubist said it submitted an sNDA to FDA for Entereg alvimopan to accelerate GI recovery following any surgery that includes...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >